Astrid Paul Nordin, MD, PhD, discusses the results of the IDEAL-AF trial, highlighting the efficacy of including LVZ on top of PVI.
Astrid Paul Nordin, MD, PhD
Advertisement
Astrid Paul Nordin, MD, PhD, is a consultant cardiologist in electrophysiology at the Karolinska University Hospital.
Articles by Astrid Paul Nordin, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
FDA Approves Finerenone (Kerendia) for CKD and Type 1 Diabetes
2
Vicadrostat EASi-KIDNEY Trial Discontinued for Lack of Benefit in CKD
3
ASH Issues New Ferritin Thresholds for Iron Deficiency Diagnosis
4
Immediate Coronary Angiography Does Not Improve Survival Outcomes in Cardiac Arrest
5